WallStreetZenWallStreetZen

NASDAQ: MGNX
Macrogenics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Macrogenics earnings were -$75.9M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest MGNX earnings report on Sep 30, 2025 announced Q3 2025 earnings of $16.8M, down 146.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MGNX reported annual earnings of -$67.0M, with 639.3% growth. The next MGNX earnings date is Feb 19, 2026.

MGNX earnings history

Current Revenue
$127.6M
Current Earnings
-$75.9M
Current Profit Margin
-59.5%

MGNX Return on Equity

Current Company
-98.3%
Current Industry
-21.2%
Current Market
35.1%
MGNX's Return on Equity (-98.3%)... subscribe to Premium to read more.
High Return on Equity Performance

MGNX Return on Assets

Current Company
-30.3%
Current Industry
-8.8%
MGNX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MGNX announces earnings.

MGNX Return on Capital Employed

Current Company
-31.21%
Current Industry
-3.5%
MGNX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MGNX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MGNX-$64.40M-$75.89MN/A-$1.20
PRLD-$108.45M-$111.77MN/A-$1.47
CRDF-$49.65M-$50.45MN/A-$0.79
IKT-$47.59M-$47.66MN/A$0.48
CDXS-$48.63M-$63.95MN/A-$0.74
View Top Biotech Stocks

MGNX earnings dates

Next earnings date
Feb 19, 2026

Macrogenics Earnings Reports & History FAQ

What were Macrogenics's earnings last quarter?

On MGNX's earnings call on Invalid Date, Macrogenics (NASDAQ: MGNX) reported Q3 2025 earnings per share (EPS) of $0.27, up 70% year over year. Total MGNX earnings for the quarter were $16.82 million. In the same quarter last year, Macrogenics's earnings per share (EPS) was $0.90.

If you're new to stock investing, here's how to buy Macrogenics stock.

When does Macrogenics report earnings?

The next MGNX earnings date is Invalid Date. Add MGNX to your watchlist to be reminded of Macrogenics's next earnings date.

Is Macrogenics profitable or losing money?

As of the last Macrogenics earnings report, Macrogenics is currently losing money. Macrogenics's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$75.89 million, a 22.26% decrease year over year.

What was MGNX's earnings growth in the past year?

As of Macrogenics's earnings date in Invalid Date, Macrogenics's earnings has grown year over year. MGNX earnings in the past year totalled -$75.89 million.

What are Macrogenics's earnings expectations?

The current EPS estimate for Macrogenics's earnings report in Invalid Date is -$0.27.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.